Financial News
Press Releases about Acorda Therapeutics
![](https://mms.businesswire.com/media/20230131006066/en/1596352/5/Acorda_Logo-Color_Print.jpg)
Acorda Therapeutics to Present at Sequire Biotechnology Conference
January 31, 2023
From Acorda Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20230105006013/en/1596352/5/Acorda_Logo-Color_Print.jpg)
![](https://mms.businesswire.com/media/20221222005261/en/1596352/5/Acorda_Logo-Color_Print.jpg)
Acorda Therapeutics Announces Revised Long-Term Financial Guidance
December 22, 2022
From Acorda Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221220005771/en/1596352/5/Acorda_Logo-Color_Print.jpg)
![](https://mms.businesswire.com/media/20221205005244/en/1596352/5/Acorda_Logo-Color_Print.jpg)
![](https://mms.businesswire.com/media/20221111005323/en/1596352/5/Acorda_Logo-Color_Print.jpg)
![](https://mms.businesswire.com/media/20221104005393/en/1596352/5/Acorda_Logo-Color_Print.jpg)
From Acorda Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221101006228/en/1596352/5/Acorda_Logo-Color_Print.jpg)
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
November 01, 2022
From Acorda Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221027005410/en/1596352/5/Acorda_Logo-Color_Print.jpg)
From Acorda Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221025005887/en/1596352/5/Acorda_Logo-Color_Print.jpg)
![](https://mms.businesswire.com/media/20221021005074/en/1596352/5/Acorda_Logo-Color_Print.jpg)
Acorda Shareholders Invited to Virtual Q&A with CEO Ron Cohen, M.D.
October 21, 2022
From Acorda Therapeutics
Via Business Wire
![](https://mms.businesswire.com/media/20221019005311/en/1596352/5/Acorda_Logo-Color_Print.jpg)
![](https://mms.businesswire.com/media/20221018005332/en/1596352/5/Acorda_Logo-Color_Print.jpg)
![](https://mms.businesswire.com/media/20221016005046/en/1596352/5/Acorda_Logo-Color_Print.jpg)
![](https://mms.businesswire.com/media/20221010005213/en/1596341/5/Acorda_Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220616005175/en/1488228/5/AC_LOGO_300dpiJPG.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
John Varian Joins Acorda Therapeutics Board of Directors
January 03, 2022
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
November 02, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.